Objective To develop clinical practice guidelines for a simplified approach to primary
prevention of cardiovascular disease (CVD), concentrating on CVD risk estimation and lipid …

Objective To update the 2015 clinical practice guideline and provide a simplified approach
to lipid management in the prevention of cardiovascular disease (CVD) for primary care …

OBJECTIVE: In primary prevention of atherosclerotic disease, it is difficult to decide when
medical treatment should be initiated. The main goal of the study was to compare different …

Dyslipidemia is a fundamental risk factor for cardiovascular diseases (CVDs) and can
worsen the prognosis, if unaddressed. Lipid guidelines are still evolving as dyslipidemia is …

Methods The Guideline Development Group followed standard NICE methodology for the
development of this guidance (www. nice. org. uk/page. aspx? o= 114219). The guideline …

Background Little is known about the opinions of primary care clinicians regarding the newly
released 2013 American College of Cardiology/American Heart Association (ACC/AHA) …

Background The WHO recommends that those with established cardiovascular disease
should be treated with lipid-lowering therapy, but there is no specific guidance regarding …

This fully updated revision of the well-received first edition provides a clear, comprehensive
and up-to-date account of the role of lipid management in the prevention of coronary heart …

This retrospective study, conducted as part of a private practice quality assurance process
for patients with coronary artery disease (CAD), compares practice patterns in the LIFEHELP …

Cardiovascular disease is the leading cause of death in the United States. In 2010, the
Centers for Disease Control and Prevention estimated that $444 billion was spent on …